C Shih
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 2
- Nutrition and Dietetics top 1%
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 3
- Cancer-related Molecular Pathways 3
- Cancer Treatment and Pharmacology 2
- Rheumatology top 5%
- Folate and B Vitamins Research 3
-
- Biochemical and Molecular Research 10
- Molecular Biology Techniques and Applications 2
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- E. J. CoreyJohn R. CashmanRobert A. LewisK. Frank AustenRichard M. SchultzVinod F. PatelJesse R. BewleyL G Mendelsohn
- Journals
- Journal of Biological Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- United StatesTaiwanMalaysia
In The Last Decade
C Shih
22 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Biochemistry 346
- Nutrition and Dietetics 591
- Oncology 448
- Pulmonary and Respiratory Medicine 476
- Rheumatology 166
Countries citing papers authored by C Shih
This map shows the geographic impact of C Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Shih more than expected).
Fields of papers citing papers by C Shih
This network shows the impact of papers produced by C Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Shih. The network helps show where C Shih may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Shih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway ; Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway | 2015 | 2 |
| 3 | Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts. | 2002 | 24 |
| 4 | 2001 | 11 | |
| 5 | 2000 | 5 | |
| 6 | Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514. | 1999 | 101 |
| 7 | Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells. | 1999 | 16 |
| 8 | 1998 | 50 | |
| 9 | 1998 | 4 | |
| 10 | A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase. | 1998 | 1 |
| 11 | LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. | 1997 | 490 |
| 12 | Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid. | 1996 | 56 |
| 13 | A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. | 1994 | 54 |
| 14 | 1993 | 7 | |
| 15 | 1992 | 16 | |
| 16 | 1990 | 2 | |
| 17 | 1989 | 94 | |
| 18 | Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.breakdown → | 1984 | 235 |
| 19 | Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.breakdown → | 1984 | 222 |
| 20 | Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.breakdown → | 1983 | 355 |
About C Shih
C Shih is a scholar working on Cancer Research, Toxicology, Biochemistry, Geriatrics and Gerontology and Physiology, having authored 22 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (10 papers), Cancer, Hypoxia, and Metabolism (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Folate and B Vitamins Research (3 papers), Molecular Biology Techniques and Applications (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Biochemistry (346 citations), Nutrition and Dietetics (591 citations), Oncology (448 citations), Pulmonary and Respiratory Medicine (476 citations) and Rheumatology (166 citations). C Shih has collaborated with scholars based in United States, Taiwan and Malaysia. Frequent co-authors include E. J. Corey, John R. Cashman, Robert A. Lewis, K. Frank Austen, Richard M. Schultz, Vinod F. Patel, Jesse R. Bewley, L G Mendelsohn, Sherri L. Andis and Jean‐Michel Mencia‐Huerta. Their work appears in journals such as Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, British Journal of Cancer, Oncology Reports and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.